Every 10-Q that DSS, Inc. (DSS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow DSS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DSS filings page.
DSS, Inc. reports weaker results for the quarter and six months ended June 30, 2026. Total revenue for the quarter was $3.6 million versus $5.3 million a year earlier, and $7.9 million for the six-month period versus $10.2 million. The company recorded an operating loss of $3.8 million for the quarter and $9.3 million year-to-date, compared with $3.4 million and $7.2 million in the prior-year periods.
Net loss attributable to common stockholders widened to $4.8 million for the quarter and $10.4 million for the six months, with basic and diluted loss per share of $0.48 and $1.06, respectively. Cash and cash equivalents declined to $4.1 million, marketable securities to $2.8 million, and current assets to $9.4 million against current liabilities of $49.2 million, resulting in a reported negative working capital position of about $39.9 million. Management discloses that these conditions raise substantial doubt about the company’s ability to continue as a going concern and outlines plans relying on asset sales, additional financing, and cost reductions.
The balance sheet reflects significant debt, including approximately $38.5 million under a LifeCare real estate loan that is in default and past due. DSS also reports large credit loss reserves on notes receivable and continues to engage in related-party financing and investment transactions, including an equity method investment in True Partners Capital Holding Limited and convertible financing arrangements with Alset-affiliated entities. As of August 5, 2026, there were 10,042,518 common shares outstanding.
DSS, Inc. reported a larger net loss for the quarter ended March 31, 2026 and raised substantial doubt about its ability to continue as a going concern. Revenue fell to $4.33 million from $4.95 million a year earlier, while cost of revenue and higher selling, general and administrative expenses drove an operating loss of $5.49 million versus $3.73 million in 2025.
Net loss widened to $6.35 million, or $0.60 per share, compared with $5.30 million, or $0.55 per share. Cash and cash equivalents declined to $4.94 million, and operating and investing activities used cash. DSS carries significant debt, including a large medical-facility loan in default, and disclosed substantial doubt about continuing as a going concern despite recognizing an $8.52 million related-party convertible bond investment that lifted total assets and stockholders’ equity.
DSS, Inc. reported Q3 2025 results showing higher revenue and a narrower loss. Quarterly revenue was $6.39 million, up from $5.60 million a year ago, driven mainly by printed products and rental income. Operating loss improved to $3.23 million from $4.67 million, and net loss attributable to common stockholders narrowed to $2.30 million from $5.28 million. For the first nine months, revenue reached $16.63 million with a net loss of $9.18 million, improving from $13.68 million and $14.03 million, respectively, in the prior year period.
Liquidity and balance sheet metrics remain tight. Cash and cash equivalents were $7.02 million at September 30, 2025. Current liabilities totaled $54.19 million, including $43.15 million of current long‑term debt, while total stockholders’ equity was $26.11 million. The company completed a $9.5 million real estate sale (recognizing a $0.73 million loss), generated $12.08 million net cash from investing, and used $8.82 million in financing, largely to repay debt. Management disclosed that recurring losses and cash burn raise substantial doubt about continuing as a going concern.